408 related articles for article (PubMed ID: 33322045)
1. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
[TBL] [Abstract][Full Text] [Related]
2. iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility.
Imamura K; Sakurai Y; Enami T; Shibukawa R; Nishi Y; Ohta A; Shu T; Kawaguchi J; Okada S; Hoenen T; Yasuda J; Inoue H
FEBS Open Bio; 2021 May; 11(5):1452-1464. PubMed ID: 33822489
[TBL] [Abstract][Full Text] [Related]
3. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.
Han Z; Lu J; Liu Y; Davis B; Lee MS; Olson MA; Ruthel G; Freedman BD; Schnell MJ; Wrobel JE; Reitz AB; Harty RN
J Virol; 2014 Jul; 88(13):7294-306. PubMed ID: 24741084
[TBL] [Abstract][Full Text] [Related]
5. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
6. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
[TBL] [Abstract][Full Text] [Related]
7. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
[TBL] [Abstract][Full Text] [Related]
8. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
9. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle.
Surtees R; Dowall SD; Shaw A; Armstrong S; Hewson R; Carroll MW; Mankouri J; Edwards TA; Hiscox JA; Barr JN
J Virol; 2016 Oct; 90(20):9305-16. PubMed ID: 27512070
[TBL] [Abstract][Full Text] [Related]
10. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
Weston S; Baracco L; Keller C; Matthews K; McGrath ME; Logue J; Liang J; Dyall J; Holbrook MR; Hensley LE; Jahrling PB; Yu W; MacKerell AD; Frieman MB
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30687-30698. PubMed ID: 33184176
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Mounce BC; Cesaro T; Moratorio G; Hooikaas PJ; Yakovleva A; Werneke SW; Smith EC; Poirier EZ; Simon-Loriere E; Prot M; Tamietti C; Vitry S; Volle R; Khou C; Frenkiel MP; Sakuntabhai A; Delpeyroux F; Pardigon N; Flamand M; Barba-Spaeth G; Lafon M; Denison MR; Albert ML; Vignuzzi M
J Virol; 2016 Nov; 90(21):9683-9692. PubMed ID: 27535047
[TBL] [Abstract][Full Text] [Related]
13. Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses.
Galindo I; Garaigorta U; Lasala F; Cuesta-Geijo MA; Bueno P; Gil C; Delgado R; Gastaminza P; Alonso C
Antiviral Res; 2021 Feb; 186():104990. PubMed ID: 33249093
[TBL] [Abstract][Full Text] [Related]
14. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication.
Luthra P; Liang J; Pietzsch CA; Khadka S; Edwards MR; Wei S; De S; Posner B; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299
[TBL] [Abstract][Full Text] [Related]
15. Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir.
Gordon CJ; Lee HW; Tchesnokov EP; Perry JK; Feng JY; Bilello JP; Porter DP; Götte M
J Biol Chem; 2022 Feb; 298(2):101529. PubMed ID: 34953856
[TBL] [Abstract][Full Text] [Related]
16. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.
Bordi L; Lalle E; Caglioti C; Travaglini D; Lapa D; Marsella P; Quartu S; Kis Z; Arien KK; Huemer HP; Meschi S; Ippolito G; Di Caro A; Capobianchi MR; Castilletti C
PLoS One; 2015; 10(2):e0116816. PubMed ID: 25693189
[TBL] [Abstract][Full Text] [Related]
18. High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses.
Mudhasani R; Kota KP; Retterer C; Tran JP; Tritsch SR; Zamani R; Whitehouse CA; Bavari S
J Biomol Screen; 2015 Jan; 20(1):141-52. PubMed ID: 25342145
[TBL] [Abstract][Full Text] [Related]
19. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
20. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
